A PiRNA-like Small RNA Induces Chemoresistance to Cisplatin-Based Therapy by Inhibiting Apoptosis in Lung Squamous Cell Carcinoma

Overview

Journal Mol Ther Nucleic Acids

Publisher Cell Press

Date 2017 Mar 23

PMID 28325293

Citations 22

Authors

Yuyan Wang

Tyler Gable

Mark Z Ma

David Clark

Jun Zhao

Yi Zhang

Wei Liu

Li Mao

Yuping Mei

Affiliations

Soon will be listed here.

Abstract

Lung cancer is the leading cause of cancer-related death worldwide. Although advanced drugs have benefitted patients, therapeutic success has largely been hampered because of rapid development of resistance. Here we report that PIWI-interacting RNA likes (piR-Ls), a novel type of functional sncRNAs, play key roles in chemoresistance to cisplatin (CDDP)-based chemotherapy in lung squamous cell carcinoma (LSCC). piR-L-138 was upregulated upon CDDP-based chemotherapy both in LSCC cells and in patient-derived xenograft (PDX) LSCC models. Further, targeting upregulated piR-L-138 led to increased apoptosis in CDDP-treated LSCC cells and LSCC xenograft mice treated with CDDP. In addition, piR-L-138 directly interacted with p60-MDM2 and inhibited CDDP-activated apoptosis in p53-mutated LSCC. We identified the upregulated piR-L-138 upon CDDP-based chemotherapy, confirmed the enhanced sensitivity of LSCC to agents by targeting the upregulated piR-L-138 both in vitro and in vivo, and revealed mechanisms underlying piR-L-138 in chemoresistance, bolstering a new emerging clinical modality where novel functional piR-Ls provide potential strategies to overcome chemoresistance for patients with LSCC.

Citing Articles

piR-1919609 Is an Ideal Potential Target for Reversing Platinum Resistance in Ovarian Cancer.

Yan Y, Tian D, Zhao B, Li Z, Huang Z, Li K Technol Cancer Res Treat. 2024; 23:15330338241249692.

PMID: 38706262 PMC: 11072069. DOI: 10.1177/15330338241249692.

PIWI-interacting RNA (piRNA): a narrative review of its biogenesis, function, and emerging role in lung cancer.

Mukherjee P, Bhattacharjee S, Mandal D Asian Biomed (Res Rev News). 2023; 16(1):3-14.

PMID: 37551397 PMC: 10321162. DOI: 10.2478/abm-2022-0002.

PiRNA hsa_piR_019914 Promoted Chondrocyte Anabolic Metabolism By Inhibiting LDHA-Dependent ROS Production.

Gao Y, Yan W, Sun L, Zhang X Cartilage. 2023; 15(3):303-314.

PMID: 37431854 PMC: 11418426. DOI: 10.1177/19476035231181094.

The emerging role of the piRNA/PIWI complex in respiratory tract diseases.

Yao Y, Li Y, Zhu X, Zhao C, Yang L, Huang X Respir Res. 2023; 24(1):76.

PMID: 36915129 PMC: 10010017. DOI: 10.1186/s12931-023-02367-9.

pfeRNAs-A Novel Class of Small Non-coding RNAs With Real Translational Potential.

Mei Y, Khan H, Shishikura M, Ishiyama S, Khan A, Orita H J Surg Res. 2023; 284:237-244.

PMID: 36599285 PMC: 9911372. DOI: 10.1016/j.jss.2022.12.002.

References

Dempke W, Voigt W, Grothey A, Hill B, Schmoll H . Cisplatin resistance and oncogenes--a review. Anticancer Drugs. 2000; 11(4):225-36. DOI: 10.1097/00001813-200004000-00001. View

Zhang Z, Li M, Wang H, Agrawal S, Zhang R . Antisense therapy targeting MDM2 oncogene in prostate cancer: Effects on proliferation, apoptosis, multiple gene expression, and chemotherapy. Proc Natl Acad Sci U S A. 2003; 100(20):11636-41. PMC: 208810. DOI: 10.1073/pnas.1934692100. View

Lee H, Gu W, Shirayama M, Youngman E, Conte Jr D, Mello C . C. elegans piRNAs mediate the genome-wide surveillance of germline transcripts. Cell. 2012; 150(1):78-87. PMC: 3410639. DOI: 10.1016/j.cell.2012.06.016. View

Pao W . New approaches to targeted therapy in lung cancer. Proc Am Thorac Soc. 2012; 9(2):72-3. PMC: 3359104. DOI: 10.1513/pats.201112-054MS. View

Fire A, Xu S, Montgomery M, Kostas S, Driver S, Mello C . Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 1998; 391(6669):806-11. DOI: 10.1038/35888. View

Paez J, Janne P, Lee J, Tracy S, Greulich H, Gabriel S . EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science. 2004; 304(5676):1497-500. DOI: 10.1126/science.1099314. View

Herbst R, Heymach J, Lippman S . Lung cancer. N Engl J Med. 2008; 359(13):1367-80. PMC: 10662965. DOI: 10.1056/NEJMra0802714. View

Kwak E, Bang Y, Camidge D, Shaw A, Solomon B, Maki R . Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med. 2010; 363(18):1693-703. PMC: 3014291. DOI: 10.1056/NEJMoa1006448. View

Yan Z, Hu H, Jiang X, Maierhofer V, Neb E, He L . Widespread expression of piRNA-like molecules in somatic tissues. Nucleic Acids Res. 2011; 39(15):6596-607. PMC: 3159465. DOI: 10.1093/nar/gkr298. View

10.

Shirayama M, Seth M, Lee H, Gu W, Ishidate T, Conte Jr D . piRNAs initiate an epigenetic memory of nonself RNA in the C. elegans germline. Cell. 2012; 150(1):65-77. PMC: 3597741. DOI: 10.1016/j.cell.2012.06.015. View

11.

Ashe A, Sapetschnig A, Weick E, Mitchell J, Bagijn M, Cording A . piRNAs can trigger a multigenerational epigenetic memory in the germline of C. elegans. Cell. 2012; 150(1):88-99. PMC: 3464430. DOI: 10.1016/j.cell.2012.06.018. View

12.

Chen L, Marechal V, Moreau J, Levine A, Chen J . Proteolytic cleavage of the mdm2 oncoprotein during apoptosis. J Biol Chem. 1997; 272(36):22966-73. DOI: 10.1074/jbc.272.36.22966. View

13.

Oliver T, Meylan E, Chang G, Xue W, Burke J, Humpton T . Caspase-2-mediated cleavage of Mdm2 creates a p53-induced positive feedback loop. Mol Cell. 2011; 43(1):57-71. PMC: 3160283. DOI: 10.1016/j.molcel.2011.06.012. View

14.

Mei Y, Zhang P, Zuo H, Clark D, Xia R, Li J . Ebp1 activates podoplanin expression and contributes to oral tumorigenesis. Oncogene. 2013; 33(29):3839-50. DOI: 10.1038/onc.2013.354. View

15.

Zhang Z, Wang H, Li M, Agrawal S, Chen X, Zhang R . MDM2 is a negative regulator of p21WAF1/CIP1, independent of p53. J Biol Chem. 2004; 279(16):16000-6. DOI: 10.1074/jbc.M312264200. View

16.

Mei Y, Wang Y, Kumari P, Shetty A, Clark D, Gable T . A piRNA-like small RNA interacts with and modulates p-ERM proteins in human somatic cells. Nat Commun. 2015; 6:7316. PMC: 4557300. DOI: 10.1038/ncomms8316. View

17.

Gottesman M, Lavi O, Hall M, Gillet J . Toward a Better Understanding of the Complexity of Cancer Drug Resistance. Annu Rev Pharmacol Toxicol. 2015; 56:85-102. DOI: 10.1146/annurev-pharmtox-010715-103111. View

18.

Chang A . Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC. Lung Cancer. 2010; 71(1):3-10. DOI: 10.1016/j.lungcan.2010.08.022. View

19.

Bouska A, Eischen C . Mdm2 affects genome stability independent of p53. Cancer Res. 2009; 69(5):1697-701. DOI: 10.1158/0008-5472.CAN-08-3732. View

20.

Ross R, Weiner M, Lin H . PIWI proteins and PIWI-interacting RNAs in the soma. Nature. 2014; 505(7483):353-359. PMC: 4265809. DOI: 10.1038/nature12987. View